US equities
|
MU
$1,039.54
▼-4.45%
NVDA
$230.16
▼-3.08%
SNDK
$1,607.00
▼-5.05%
AMD
$616.89
▼-4.49%
INTC
$106.28
▼-6.05%
SPCX
$162.21
▼-3.22%
META
$718.42
▼-0.40%
MSFT
$521.98
▼-1.47%
MU
$1,039.54
▼-4.45%
NVDA
$230.16
▼-3.08%
SNDK
$1,607.00
▼-5.05%
AMD
$616.89
▼-4.49%
INTC
$106.28
▼-6.05%
SPCX
$162.21
▼-3.22%
META
$718.42
▼-0.40%
MSFT
$521.98
▼-1.47%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about TSX:CRDL
Recent news which mentions TSX:CRDL
Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol
October 11, 2023
Tags
TSX:CRDL
NASDAQ:CRDL
From
News Direct
Cardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis
January 17, 2023
Tags
NASDAQ:CRDL
TSX:CRDL
From
News Direct
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
December 16, 2022
Tags
TSX:CRDL
NASDAQ:CRDL
From
News Direct